ISHAGE-based single-platform flowcytometric analysis for measurement of absolute viable T cells in fresh or cryopreserved products:: CD34/CD133 selected or CD3/CD19 depleted stem cells, DLI and purified CD56+CD3- NK cells

被引:27
|
作者
Koehl, U. [1 ]
Bochennek, K. [1 ]
Esser, R. [1 ]
Brinkmann, A. [1 ]
Quaritsch, R. [1 ]
Becker, M. [1 ]
Soerensen, J. [1 ]
Bader, P. [1 ]
Schwabe, D. [1 ]
Klingebiel, T. [1 ]
Fischer, J. [2 ]
Zimmermann, S. Y. [1 ]
机构
[1] Univ Hosp Frankfurt, Lab Stem Cell Transplantat & Immunotherapy, D-60596 Frankfurt, Germany
[2] Inst Diagnost Transplantat & Cell Therapy, Dusseldorf, Germany
关键词
DLI; graft engineering; residual T cells; single-platform method;
D O I
10.1007/s12185-007-0018-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Considering the growing use of immunotherapeutic strategies in paediatric stem cell transplantation associated with risk of graft-versus-host disease, an accurate method for the enumeration of residual T cells/kg recipient's body weight is of paramount importance. Therefore, we propose a multi colour-flow cytometric strategy for correct absolute vital T cell enumeration in manipulated cell preparations for clinical use. The gating strategy is based on the ISHAGE single-platform stem cell enumeration method in combination with experiences from lymphocyte subtyping, using low scatter, high expression of CD3 and CD45 antigens and 7-AAD staining in a no-wash-preparation with counting beads. In spiking experiments, the detection limit was determined to be at 0.7 +/- 0.5 CD3(+) cells/mu l with a minimum of 50 T cell events acquired. The cell preparations analysed contained a median absolute CD3(+) T cell number of 221 x 10(3) (0.09%, CD34 selected grafts, n = 187), 900 x 10(3) (0.004%, CD3/CD19 depleted grafts, n = 15) and 283 x 10(3) (0.012%, CD3 depleted/CD56 enriched NK-cells, n = 14), respectively. The results differed of those from conventional T cell measurement in cell products after extensive manipulation. Our method provides reliable residual T cell enumeration even at extremely low concentrations.
引用
收藏
页码:98 / 105
页数:8
相关论文
共 25 条
  • [21] CD3/CD19 depleted peripheral stem cells for matched unrelated donor in combination with a reduced intensity regimen - a new option in children lacking a matched sibling donor?
    Soerensen, J
    Becker, M
    Koehl, U
    Reinhard, H
    Klingebiel, T
    Bader, P
    BONE MARROW TRANSPLANTATION, 2006, 37 : S328 - S328
  • [22] NK-cell recovery and immune reconstitution after haploidentical hemalopoietic cell transplantation using either CD34 selected grafts and adoptive NK-cell transfer or CID3/CD19 depleted grafts: comparison of two strategies for NK cell based immunotherapy
    Gentilini, Chiara
    Haegele, Matthias
    Muessig, Arne
    Nogai, Axel
    Kliem, Constanze
    Bartsch, Kristina
    Bazara, Nadezda
    Vogel, Wichard
    Faul, Christoph
    Kanz, Lothar
    Thiel, Eckhard
    Niederwieser, Dietger W.
    Uharek, Lutz
    Bethge, Wolfgang A.
    BLOOD, 2007, 110 (11) : 877A - 877A
  • [23] Adoptive transfer of CD3/CD28 ex vivo costimulated T cells in patients with relapsed/refractory non-Hodgkin's lymphoma (NHL) following high dose chemotherapy (HDC) with CD34-selected peripheral blood stem cell (PBSC) support.
    Laport, GG
    Liebowitz, DN
    Williams, SF
    Zimmerman, TM
    Felix, CA
    Stadtmauer, EA
    Schuster, SJ
    Luger, S
    Tsai, DE
    Strobl, FJ
    Bennett, P
    O'Connell, M
    Levine, BL
    June, CH
    Porter, DL
    BLOOD, 2000, 96 (11) : 407A - 407A
  • [24] Kinetic of CD3, CD33, CD34 positive donor cells and LTC-IC after non-myeloablative stem cell transplantation:: significant prognostic impact of donor T-cell chimerism on disease free survival and suppression of LTC-IC after non-myeloablative conditioning
    Keil, F
    Prinz, E
    Moser, K
    Kalhs, P
    Mannhalter, C
    Höcker, P
    Worel, N
    Lechner, K
    Greinix, H
    BONE MARROW TRANSPLANTATION, 2002, 29 : S154 - S154
  • [25] The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their ex vivo Expansion and Cytotoxic Potential Against Neuroblastoma: Perspective for Optimized Immunotherapy Post Haploidentical Stem Cell Transplantation
    Heinze, Annekathrin
    Grebe, Beatrice
    Bremm, Melanie
    Huenecke, Sabine
    Munir, Tasleem Ah
    Graafen, Lea
    Frueh, Jochen T.
    Merker, Michael
    Rettinger, Eva
    Soerensen, Jan
    Klingebiel, Thomas E.
    Bader, Peter
    Ullrich, Evelyn
    Cappel, Claudia
    FRONTIERS IN IMMUNOLOGY, 2019, 10